Pb2305: efgartigimod: clinical development of a novel fcrn antagonist in the treatment of autoimmune diseases

P. Knoebl,H. de Haard,W. Parys,P. Ulrichts, F. Rocca,A. Guglietta, J. Ayguasanosa

HemaSphere(2022)

引用 0|浏览0
暂无评分
关键词
novel fcrn antagonist,efgartigimod
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要